These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. Li EK; Tam LS J Rheumatol; 1999 Sep; 26(9):1923-9. PubMed ID: 10493670 [TBL] [Abstract][Full Text] [Related]
4. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Pan TL; Thumboo J; Boey ML Lupus; 2000; 9(5):338-42. PubMed ID: 10878725 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Cefle A; Inanc M; Sayarlioglu M; Kamali S; Gul A; Ocal L; Aral O; Konice M Rheumatol Int; 2011 Feb; 31(2):183-9. PubMed ID: 20012052 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566 [TBL] [Abstract][Full Text] [Related]
7. [Systemic lupus erythematosus associated pulmonary arterial hypertension: clinical analysis of 91 cases]. Teng J; Zhang W Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):969-72. PubMed ID: 24851680 [TBL] [Abstract][Full Text] [Related]
8. Is there a difference in systemic lupus erythematosus with and without Raynaud's phenomenon? Pavlov-Dolijanovic S; Damjanov NS; Vujasinovic Stupar NZ; Marcetic DR; Sefik-Bukilica MN; Petrovic RR Rheumatol Int; 2013 Apr; 33(4):859-65. PubMed ID: 22618491 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study. Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760 [TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort. Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A; Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of the pulmonary arterial systolic pressure to predict pulmonary arterial wedge pressure in patients with normal left ventricular systolic function. Bouchard JL; Aurigemma GP; Hill JC; Ennis CA; Tighe DA Am J Cardiol; 2008 Jun; 101(11):1673-6. PubMed ID: 18489950 [TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Rodriguez VE; Gonzalez-Pares EN; Rivera C P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096 [TBL] [Abstract][Full Text] [Related]
14. Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study. Castillo-Martínez D; Marroquín-Fabián E; Lozada-Navarro AC; Mora-Ramírez M; Juárez M; Sánchez-Muñoz F; Vargas-Barrón J; Sandoval J; Amezcua-Guerra LM Lupus; 2016 Jan; 25(1):61-6. PubMed ID: 26306740 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus. Caspary L; Schmees C; Schoetensack I; Hartung K; Stannat S; Deicher H; Creutzig A; Alexander K J Rheumatol; 1991 Apr; 18(4):559-66. PubMed ID: 2066948 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in systemic lupus erythematosus. Simonson JS; Schiller NB; Petri M; Hellmann DB J Rheumatol; 1989 Jul; 16(7):918-25. PubMed ID: 2769664 [TBL] [Abstract][Full Text] [Related]
17. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188 [TBL] [Abstract][Full Text] [Related]
18. An autopsied case of systemic lupus erythematosus with pulmonary hypertension--a case report. KanemotO N; Sato M; Moriuchi J; Ichikawa Y; Goto Y; Sasadaira H Angiology; 1988 Feb; 39(2):187-92. PubMed ID: 3348494 [TBL] [Abstract][Full Text] [Related]
19. Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus. Buyukhatipoglu H; Buyukaslan H; Pehlivan Y; Ceylan N; Ulas T; Tarakcioglu M; Onat AM Int J Rheum Dis; 2011 Aug; 14(3):276-81. PubMed ID: 21816024 [TBL] [Abstract][Full Text] [Related]
20. Alopecia in systemic lupus erythematosus. Relation to disease manifestations. Wysenbeek AJ; Leibovici L; Amit M; Weinberger A J Rheumatol; 1991 Aug; 18(8):1185-6. PubMed ID: 1941821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]